Results 41 to 50 of about 1,472,401 (258)
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background An internal tandem duplication in the gene encoding Fms‐like tyrosine kinase 3 (FLT3‐ITD) is associated with high relapse risk and poor prognosis in acute myeloid leukemia (AML) and plays a crucial role in treatment decisions. Measurable residual disease (MRD) analysis of FLT3‐ITD during and after treatment has shown prognostic ...
Sofie Johansson Alm +11 more
wiley +1 more source
A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma
Endocrine Connections, 2017 The prognostic role of molecular markers in papillary thyroid carcinoma (PTC) is a matter of ongoing debate. The aim of our study is to investigate the impact of RAS, BRAF, TERT promoter mutations and RET/PTC rearrangements on the prognosis of PTC ...
Huy Gia Vuong +7 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Claudin‐6 has emerged as a promising immunotherapeutic target, yet protein‐level data in atypical teratoid/rhabdoid tumors (AT/RTs) have been inconsistent. We analyzed 36 well‐characterized AT/RT samples and found membranous claudin‐6 protein expression in 58% of cases, with striking enrichment in the molecular subgroup AT/RT‐TYR (100%) and ...
Victoria E. Fincke +4 more
wiley +1 more source
Optimal cut-off age for AJCC staging system in Middle Eastern differentiated thyroid cancer
Frontiers in EndocrinologyBackgroundAge cut-off of 55 years has been included in the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging, since it led to better prediction of disease-specific survival (DSS) of patients with differentiated thyroid cancer ...
Sandeep Kumar Parvathareddy +7 more
doaj +1 more source
World Journal of Surgery, 2015 AbstractBackgroundNomogram could estimate individualized prognosis in papillary thyroid carcinoma (PTC). We aimed to create and validate a new nomogram and compare it with other published nomograms using a large patient cohort.MethodsEight‐hundred and forty‐nine PTC patients with ≥7 years follow‐up were randomly assigned to the development (n = 425 ...
Lang, HHB, Wong, CKH
openaire +4 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Wilms tumor (WT) treatment imposes a significant time burden on patients and their families. Time toxicity is a patient‐centered metric that quantifies the burden of healthcare interaction. We sought to define time toxicity in the first year after diagnosis of WT and hypothesized that it would increase as tumor stage and treatment ...
Caleb Q. Ashbrook +6 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Central nervous system (CNS) involvement in childhood acute lymphoblastic leukemia (ALL) is assessed by cell counting and cytomorphology from cerebrospinal fluid (CSF) and is used for treatment stratification worldwide. The ratio of “CNS2” patients in clinical trials ranges from 3% to 40%, with unclear prognostic significance ...
Laura Almási +14 more
wiley +1 more source
Frontiers in Oncology, 2015 Purpose: We aimed to externally validate the association of 2- and 3-year disease-free survival with 5-year overall survival in patients treated with radical cystectomy for urothelial carcinoma of the bladder.
Hyung Suk eKim +4 more
doaj +1 more source
Insights into Imaging, 2022 Background Tumor size assessment by MRI is central for staging uterine cervical cancer. However, the optimal role of MRI-derived tumor measurements for prognostication is still unclear.
Njål Lura +9 more
doaj +1 more source
Effect of “Time To Surgery” on the Endometrial Cancer Prognosis
Gynecology Obstetrics & Reproductive Medicine, 2022 OBJECTIVE: Endometrial cancer is the most common gynecological cancer in developed countries. Our study aims to determine the effect of the time between diagnosis and surgery of endometrial cancer on the prognosis of the disease.
Engin Celik +6 more
doaj +1 more source